Cover Image
市場調查報告書

持續性腎功能替代療法 (CRRT:Continuous Renal Replacement Therapy) 的引進趨勢及全球市場的預測 ∼2020年:各產品、模式、地區

Continuous Renal Replacement Therapy (CRRT) Market by Products (System, Disposables (Hemofilters & Bloodlines), & Dialysate/Replacement Fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF) and Geography - Regional Adoption and Global Forecasts to 2020

出版商 MarketsandMarkets 商品編碼 344289
出版日期 內容資訊 英文 174 Pages
訂單完成後即時交付
價格
Back to Top
持續性腎功能替代療法 (CRRT:Continuous Renal Replacement Therapy) 的引進趨勢及全球市場的預測 ∼2020年:各產品、模式、地區 Continuous Renal Replacement Therapy (CRRT) Market by Products (System, Disposables (Hemofilters & Bloodlines), & Dialysate/Replacement Fluids), Modality (SCUF, CVVH, CVVHD, CVVHDF) and Geography - Regional Adoption and Global Forecasts to 2020
出版日期: 2015年10月26日 內容資訊: 英文 174 Pages
簡介

全球持續的腎功能替代療法 (CRRT:Continuous Renal Replacement Therapy) 的市場預計從2015年到2020年以7.2%的年複合成長率成長。在2015年美國、德國、英國等成熟市場雖然佔很大的佔有率,但是今後預計在預測期間中亞太地區以最高的8.7%的年複合成長率成長。高齡化發展和敗血症患者的增加,跨國公司對新興市場的焦點擴大,醫療基礎設施的改善及現代化,急性腎障礙 (AKI) 的高發病率等,成為促進該地區成長的要素。

本報告提供全球持續的腎功能替代療法 (CRRT:Continuous Renal Replacement Therapy) 的市場調查、CRRT概要、模式及構成產品種類與概要、市場成長的各種影響因素、市場機會、市場潛力相關分析、各地區的法律制度、各地區的CRRT的使用趨勢、各產品區分/種模式的市場規模的變化與預測、地區及主要國家的趨勢、競爭環境與市場佔有率,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 市場潛力
  • 市場機會
  • 各產品、模式的市場實際成果、預測
  • 各種模式市場現狀
  • 各國市場實際成果、預測

第5章 市場概要

  • 簡介
  • 市場區隔
  • 市場動態
    • 市場推動要素
    • 阻礙市場要素
    • 市場機會
    • 課題
    • 成功必要條件
    • 產業趨勢

第6章 產業分析

  • 簡介
  • 償付方案
    • 北美
    • 歐洲
    • 亞太地區
    • 日本
    • 其他
  • 法律制度
    • 北美
    • 歐洲
    • 亞太地區
    • 其他
  • 波特的五力分析
  • 價格、成本分析
  • 策略性建議

第7章 CRRT的引進:各地區

  • 簡介
  • CRRT的有效利用趨勢:各地區
  • CRRT患者數:各地區

第8章 CRRT市場:各產品

  • 簡介
    • 透析液、置換液
    • CRRT拋棄式用品
      • 血液過濾器
      • 管套組
      • 其他
    • CRRT系統

第9章 CRRT市場:各種模式

  • 簡介
  • 連續靜靜脈血液過濾 (CVVH:CONTINUOUS VENOVENOUS HEMOFILTRATION)
  • 連續靜靜脈血液過濾透析 (CVVHDF:CONTINUOUS VENOVENOUS HEMODIAFILTRATION)
  • 連續靜靜脈血液透析 (CVVHD:CONTINUOUS VENOVENOUS HEMODIALYSIS)
  • SCUF (SLOW-CONTINUOUS ULTRAFILTRATION)

第10章 各地區市場

  • 簡介
  • CRRT市場:各地區
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 其他
    • 北美
      • 美國
      • 加拿大
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 其他
    • 其他地區
      • 南非
      • 南美、中東

第11章 競爭環境

  • 競爭的強度
    • 各種參數&評分的評估
    • 評分手法
    • 競爭強度評分:各企業
    • 競爭強度製圖:BAXTER、NXSTAGE、B.BRAUN、FRESENIUS
    • 市場佔有率分析
  • 競爭情形、趨勢
    • 產品的認證、市場投入、強化
    • 擴張
    • 收購
    • 協定、聯盟、合作

第12章 企業簡介

  • 簡介
  • BAXTER INTERNATIONAL INC.
  • FRESENIUS MEDICAL CARE AG & CO. KGAA
  • 日機裝
  • B. BRAUN MELSUNGEN AG
  • NXSTAGE MEDICAL, INC.
  • 旭化成醫學 (旭化成醫學子公司)
  • BELLCO S.R.L.
  • INFOMED SA
  • MEDICA S.P.A
  • MEDICAL COMPONENTS, INC.
  • TORAY MEDICAL COMPANY LIMITED
    • 產業概要
    • 產品與服務
    • 近幾年的發展趨勢
    • SWOT分析
    • MNM的見解等

第13章 附錄

圖表

目錄
Product Code: MD 3842

The global CRRT market is estimated to grow at a CAGR of 7.2% from 2015 to 2020. Although mature markets such as the U.S., Germany, and the U.K. held larger shares in the CRRT market in 2015, Asia-Pacific is poised to grow at the highest CAGR of 8.7% in the next five years. Factors such as increasing aging population, rise in sepsis cases, growing focus of multinational companies on emerging markets, improvements in and the modernization of healthcare infrastructure, and high incidences of AKI cases in this region are propelling the growth of this market.

The overall growth of the CRRT market is driven by factors such as the rising prevalence of AKI, increasing prevalence of sepsis, growing number of ICU patients, rapid rise in aging population, clinical advantages of CRRT over intermittent blood purification techniques, and the preference for CRRT (it is held as a gold standard for the treatment of hemodynamically unstable patients). However, factors such as high complexity of therapy, high procedural cost of CRRT, stringent regulatory guidelines for CRRT in North America, and the dearth of trained ICU nurses are restraining the growth of this market. Moreover, emerging markets (such as China, India, Brazil, and Mexico); broadening application horizons of CRRT, ongoing researches to establish the safety and efficacy profile of CRRT, and the development of a CRRT system for pediatric patients are creating opportunities for the players involved in the market.

In this report, the global CRRT market has been segmented on the basis of product [CRRT systems, CRRT disposables (hemofilters, bloodlines, and other disposables), and dialysate and replacement fluids] and modality [slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF)].

Geographically, Europe (comprising Germany, France, the U.K., and Rest of Europe) commanded the largest share of 41% of the global CRRT market in 2015, followed by North America. The European CRRT market is primarily driven by various factors such as the increasing cases of AKI in this region and rising aging population, approvals for CRRT machines and anti-coagulating agents in Europe for multiple applications, high utilization rate of CRRT products in Europe, prescription of CRRT products by intensivists in Europe, and research studies and controlled clinical trials to obtain efficacy and safety profile of CRRT products. However, the inconsistent reimbursement scenario for CRRT procedure across European countries is one of the major factors restraining the growth of the CRRT market in this region.

The global CRRT market is highly consolidated in nature. Baxter International Inc. (U.S.) dominated the global CRRT market, with a share of ~55% in 2014, followed by Fresenius Medical Care AG & Co. KGaA (Germany). Other players include Asahi Kasei Medical Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Bellco S.r.l. (Italy), Infomed SA (Switzerland), Medica S.p.A (Italy), Medical Components, Inc. (U.S.), Nikkiso Co., Ltd (Japan), NxStage Medical, Inc. (U.S.), and Toray Medical Company Limited (Japan). Product approvals, launches, and enhancements; acquisition; and geographical expansion are the major strategies adopted by market players to achieve growth in the CRRT market.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis such as industry analysis (industry trends and Porter's five forces model), market share analysis of top ten players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the CRRT market, high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help them garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on CRRT products offered by the top 10 players in the CRRT market. The report analyzes the CRRT market by product and modality across geographies
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the CRRT market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for CRRT products across geographies
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the CRRT market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the CRRT market

TABLE OF CONTENTS

1. INTRODUCTION4

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MARKET POTENTIAL
  • 4.2. MARKET OPPORTUNITY
  • 4.3. CRRT MARKET, BY PRODUCT AND MODALITY (2015 VS. 2020)
  • 4.4. CRRT MARKET, BY MODALITY (2015)
  • 4.5. CRRT MARKET, BY COUNTRY (2015 VS. 2020)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY PRODUCT
    • 5.2.2. BY MODALITY
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Increasing prevalence of AKI
      • 5.3.1.2. Rising adoption of CRRT for the treatment of renal disorders
      • 5.3.1.3. Growing number of ICU patients
      • 5.3.1.4. Rapid rise in aging population
      • 5.3.1.5. Clinical advantages of CRRT over intermittent blood purification techniques
      • 5.3.1.6. CRRT is a gold standard for treatment of hemodynamically unstable patients
      • 5.3.1.7. Technological advancements and new product launches
      • 5.3.1.8. Increasing prevalence of sepsis
    • 5.3.2. RESTRAINTS
      • 5.3.2.1. High complexity of therapy
        • 5.3.2.1.1. Lack of standard treatment guidelines
        • 5.3.2.1.2. Complications associated with CRRT
      • 5.3.2.2. High procedural cost of CRRT
      • 5.3.2.3. Stringent regulatory guidelines for CRRT in North America
      • 5.3.2.4. Dearth of trained ICU nurses
    • 5.3.3. OPPORTUNITIES
      • 5.3.3.1. Emerging markets
      • 5.3.3.2. Broadening application horizon of CRRT
        • 5.3.3.2.1. Evolution of CRRT from simple renal replacement treatment to a multi-organ support therapy (MOST)
        • 5.3.3.2.2. CRRT: Progression from adaptive renal devices to multipurpose treatment machines
      • 5.3.3.3. Ongoing researches to establish safety and efficacy profile of CRRT
      • 5.3.3.4. Development of a CRRT system for pediatric patients
        • 5.3.3.4.1. The CARPEDIEM project
      • 5.3.3.5. Untapped market growth opportunities in North America
    • 5.3.4. CHALLENGES
      • 5.3.4.1. Poor reimbursement scenario in developing countries
      • 5.3.4.2. Lack of substantial clinical evidences supporting efficacy of CRRT
      • 5.3.4.3. Currently approved CRRT technology is inadequate for children
      • 5.3.4.4. Lack of awareness about the benefits of CRRT
    • 5.3.5. WINNING IMPERATIVES
      • 5.3.5.1. Selling machines along with disposables to end users.
      • 5.3.5.2. High bargaining margins on disposables as well as machines
      • 5.3.5.3. Development of CRRT machine that is only compatible with respective company's disposables
      • 5.3.5.4. Core competency of players
    • 5.3.6. INDUSTRY TRENDS
      • 5.3.6.1. Training programs for the operation of CRRT devices
      • 5.3.6.2. Rising adoption of user-friendly CRRT machines

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. REIMBURSEMENT SCENARIO
    • 6.2.1. NORTH AMERICA
    • 6.2.2. EUROPE
    • 6.2.3. ASIA-PACIFIC (EXCLUDING JAPAN)
    • 6.2.4. JAPAN
    • 6.2.5. REST OF THE WORLD
  • 6.3. REGULATORY LANDSCAPE
    • 6.3.1. NORTH AMERICA
    • 6.3.2. EUROPE
    • 6.3.3. ASIA-PACIFIC
    • 6.3.4. REST OF THE WORLD
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. COMPETITIVE INTENSITY
    • 6.4.2. BARGAINING POWER OF BUYERS
    • 6.4.3. BARGAINING POWER OF SUPPLIERS
    • 6.4.4. THREAT OF SUBSTITUTES
    • 6.4.5. THREAT OF NEW ENTRANTS
  • 6.5. PRICING AND COST ANALYSIS
  • 6.6. STRATEGIC RECOMMENDATIONS
    • 6.6.1. DESIGN RECOMMENDATIONS FOR CRRT MACHINES
    • 6.6.2. KEY STRATEGIES FOR PLAYERS SEEKING TO ENTER THE CRRT MARKET

7. ADOPTION OF CRRT, BY REGION

  • 7.1. INTRODUCTION
  • 7.2. UTILIZATION OF CRRT PROCEDURES, BY REGION
  • 7.3. NUMBER OF CRRT PATIENTS, BY REGION

8. CRRT MARKET, BY PRODUCT

  • 8.1. INTRODUCTION
    • 8.1.1. DIALYSATE AND REPLACEMENT FLUIDS
    • 8.1.2. CRRT DISPOSABLES
      • 8.1.2.1. Hemofilters
      • 8.1.2.2. Bloodline Sets (Tubing Sets)
      • 8.1.2.3. Other Disposables
    • 8.1.3. CRRT SYSTEMS

9. CRRT MARKET, BY MODALITY

  • 9.1. INTRODUCTION
  • 9.2. CONTINUOUS VENOVENOUS HEMOFILTRATION (CVVH)
  • 9.3. CONTINUOUS VENOVENOUS HEMODIAFILTRATION (CVVHDF)
  • 9.4. CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD)
  • 9.5. SLOW-CONTINUOUS ULTRAFILTRATION (SCUF)

10. CRRT MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. CRRT MARKET, BY REGION
    • 10.2.1. EUROPE
      • 10.2.1.1. CRRT machines approved for multiple applications
      • 10.2.1.2. Intensivists' preference for CRRT for AKI treatment
      • 10.2.1.3. Players focus on leveraging growth opportunities in Europe
      • 10.2.1.4. Germany
        • 10.2.1.4.1. Rising focus of players on the German CRRT market
      • 10.2.1.5. U.K.
        • 10.2.1.5.1. Rising awareness about AKI in U.K.
      • 10.2.1.6. France
        • 10.2.1.6.1. Symposia and conferences
      • 10.2.1.7. Rest of Europe
        • 10.2.1.7.1. Clinical research and trials driving market growth in RoE
    • 10.2.2. NORTH AMERICA
      • 10.2.2.1. North American utilization of CRRT lower than that of Europe, Australia, and Japan
      • 10.2.2.2. Regulatory policies, a key hindrance to market growth
      • 10.2.2.3. U.S.
        • 10.2.2.3.1. Prevalence of AKI, ESRD rising due to growth in aging population
        • 10.2.2.3.2. Technological advancement to boost demand for CRRT products
        • 10.2.2.3.3. Ongoing clinical trials to prove safety and efficacy of CRRT products
        • 10.2.2.3.4. Government funding & grants to develop cost-effective treatments for AKI patients
        • 10.2.2.3.5. Shortage of registered nurses in ICU settings
      • 10.2.2.4. Canada
        • 10.2.2.4.1. Rising AKI prevalence
        • 10.2.2.4.2. Barriers to enter the Canadian CRRT market
        • 10.2.2.4.3. High costs of CRRT as compared to IHD
    • 10.2.3. ASIA-PACIFIC
      • 10.2.3.1. High use of CRRT in Australia and Japan
      • 10.2.3.2. Studies and clinical trials to establish the safety and efficacy profile of CRRT
      • 10.2.3.3. Dearth of reimbursement and technical expertise
      • 10.2.3.4. Japan
        • 10.2.3.4.1. Japan focusing on the use of CRRT for non-renal indications
        • 10.2.3.4.2. Large number of domestic manufacturers - a barrier to the entry of major players
      • 10.2.3.5. China
        • 10.2.3.5.1. Rising incidence of AKI and ESRD in the China
      • 10.2.3.6. India
      • 10.2.3.7. Rest of Asia-Pacific
        • 10.2.3.7.1. High utilization of CRRT in Australia
    • 10.2.4. REST OF THE WORLD (ROW)
      • 10.2.4.1. South Africa
      • 10.2.4.2. Latin America and the Middle East

11. COMPETITIVE INTELLIGENCE ANALYSIS

  • 11.1. COMPETITIVE INTENSITY
    • 11.1.1. EVALUATION PARAMETERS AND SCORES
    • 11.1.2. SCORING METHODOLOGY
    • 11.1.3. COMPETITIVE INTENSITY SCORE, BY COMPANY
      • 11.1.3.1. Baxter International Inc.
      • 11.1.3.2. NxStage Medical, Inc.
      • 11.1.3.3. B. Braun Melsungen AG
      • 11.1.3.4. Fresenius Medical Care AG & Co. KGaA
    • 11.1.4. COMPETITIVE INTENSITY - MAPPING OF BAXTER, NXSTAGE, B.BRAUN, AND FRESENIUS
    • 11.1.5. MARKET SHARE ANALYSIS
      • 11.1.5.1. Baxter International Inc.
      • 11.1.5.2. Fresenius Medical Care AG & Co. KGaA
      • 11.1.5.3. NxStage Medical, Inc.
  • 11.2. COMPETITIVE SITUATION AND TRENDS
    • 11.2.1. PRODUCT APPROVALS, LAUNCHES, AND ENHANCEMENTS
    • 11.2.2. EXPANSIONS
    • 11.2.3. ACQUISITIONS
    • 11.2.4. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS

12. COMPANY PROFILES (Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. BAXTER INTERNATIONAL INC.
  • 12.3. FRESENIUS MEDICAL CARE AG & CO. KGAA
  • 12.4. NIKKISO CO., LTD.
  • 12.5. B. BRAUN MELSUNGEN AG
  • 12.6. NXSTAGE MEDICAL, INC.
  • 12.7. ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF ASAHI KASEI CORPORATION)
  • 12.8. BELLCO S.R.L.
  • 12.9. INFOMED SA
  • 12.10. MEDICA S.P.A
  • 12.11. MEDICAL COMPONENTS, INC.
  • 12.12. TORAY MEDICAL COMPANY LIMITED

*Details on Business Overview, Products & Services, Key Insights, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.4. AVAILABLE CUSTOMIZATIONS
  • 13.5. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: USE OF CRRT AS A GOLD STANDARD FOR TREATMENT OF HEMODYNAMICALLY UNSTABLE PATIENTS IS DRIVING MARKET GROWTH
  • TABLE 2: HIGH PROCEDURAL COST OF CRRT RESTRAINING THE MARKET GROWTH
  • TABLE 3: EVOLUTION OF CRRT FROM SIMPLE RENAL REPLACEMENT TREATMENT TO MULTIPURPOSE THERAPY UNFOLDS NEW GROWTH OPPORTUNITIES
  • TABLE 4: LACK OF SUBSTANTIAL CLINICAL EVIDENCES SUPPORTING EFFICACY OF CRRT POSES A KEY CHALLENGE FOR THE MARKET
  • TABLE 5: AVERAGE SELLING PRICE (ASP) OF CRRT MACHINES, BY MANUFACTURER, 2014
  • TABLE 6: AVERAGE SELLING PRICE OF CRRT BLOODLINES AND DIALYSATE BAGS, 2014
  • TABLE 7: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 8: CRRT DIALYSATE & REPLACEMENT FLUIDS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: EUROPE: CRRT DIALYSATE & REPLACEMENT FLUIDS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 10: NORTH AMERICA: CRRT DIALYSATE & REPLACEMENT FLUIDS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 11: ASIA-PACIFIC: CRRT DIALYSATE & REPLACEMENT FLUIDS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 12: CRRT MARKET SIZE, BY DISPOSABLES, 2013-2020 (USD MILLION)
  • TABLE 13: CRRT DISPOSABLES MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 14: EUROPE: CRRT DISPOSABLES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 15: NORTH AMERICA: CRRT DISPOSABLES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 16: ASIA-PACIFIC: CRRT DISPOSABLES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 17: CRRT SYSTEMS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: EUROPE: CRRT SYSTEMS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 19: NORTH AMERICA: CRRT SYSTEMS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 20: ASIA-PACIFIC: CRRT SYSTEMS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 21: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 22: CRRT MARKET SIZE FOR CVVH, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: NORTH AMERICA: CRRT MARKET SIZE FOR CVVH, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 24: EUROPE: CRRT MARKET SIZE FOR CVVH, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 25: ASIA-PACIFIC: CRRT MARKET SIZE FOR CVVH, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 26: CRRT MARKET SIZE FOR CVVHDF, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 27: NORTH AMERICA: CRRT MARKET SIZE FOR CVVHDF, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 28: EUROPE: CRRT MARKET SIZE FOR CVVHDF, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 29: ASIA-PACIFIC: CRRT MARKET SIZE FOR CVVHDF, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 30: CRRT MARKET SIZE FOR CVVHD, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: NORTH AMERICA: CRRT MARKET SIZE FOR CVVHD, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 32: EUROPE: CRRT MARKET SIZE FOR CVVHD, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 33: ASIA-PACIFIC: CRRT MARKET SIZE FOR CVVHD, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 34: CRRT MARKET SIZE FOR SCUF, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: NORTH AMERICA: CRRT MARKET SIZE FOR SCUF, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 36: EUROPE: CRRT MARKET SIZE FOR SCUF, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 37: ASIA-PACIFIC: CRRT MARKET SIZE FOR SCUF, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 38: CRRT MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 39: EUROPE: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 40: EUROPE: CRRT PRODUCTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 41: EUROPE: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 42: EUROPE: CRRT MODALITIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 43: GERMANY: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 44: GERMANY: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 45: U.K.: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 46: U.K.: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 47: FRANCE: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 48: FRANCE: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 49: REST OF EUROPE: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 50: REST OF EUROPE: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 51: NORTH AMERICA: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 52: NORTH AMERICA: CRRT PRODUCTS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 53: NORTH AMERICA: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 54: NORTH AMERICA: CRRT MODALITIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 55: U.S.: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 56: U.S.: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 57: CANADA: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 58: CANADA: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: CRRT MARKET SIZE FOR PRODUCTS, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 61: ASIA-PACIFIC: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 62: ASIA-PACIFIC: CRRT MODALITIES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 63: JAPAN: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 64: JAPAN: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 65: CHINA: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 66: CHINA: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 67: INDIA: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 68: INDIA: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 69: REST OF ASIA-PACIFIC: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 70: REST OF ASIA-PACIFIC: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 71: ROW: CRRT MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 72: ROW: CRRT MARKET SIZE, BY MODALITY, 2013-2020 (USD MILLION)
  • TABLE 73: PRODUCT APPROVALS, LAUNCHES, AND ENHANCEMENTS, 2012-2015
  • TABLE 74: EXPANSIONS, 2012-2015
  • TABLE 75: ACQUISITIONS, 2012-2015
  • TABLE 76: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL CRRT MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: SUPPLY SIDE
  • FIGURE 4: DEMAND SIDE
  • FIGURE 5: ESTIMATION OF CRRT PROCEDURAL VOLUME
  • FIGURE 6: RESEARCH METHODOLOGY: TOP-DOWN APPROACH {FOR MARKET SIZE ESTIMATION OF DISPOSABLES (BLOODLINE SETS, HEMOFILTERS, AND WATER BAGS)}
  • FIGURE 7: RESEARCH METHODOLOGY: TOP-DOWN APPROACH (FOR MARKET-SIZE ESTIMATION OF CRRT MACHINES)
  • FIGURE 8: RESEARCH METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 9: RESEARCH DESIGN
  • FIGURE 10: DATA TRIANGULATION STEPS (TOP-DOWN AND BOTTOM-UP APPROACHES)
  • FIGURE 11: DATA TRIANGULATION METHODOLOGY
  • FIGURE 12: CRRT MARKET SEGMENTATION
  • FIGURE 13: EUROPE TO COMMAND THE LARGEST SHARE OF THE OVERALL CRRT MARKET IN 2015
  • FIGURE 14: HEMOFILTERS TO FORM THE LARGEST SEGMENT OF CRRT DISPOSABLES MARKET IN 2015
  • FIGURE 15: CVVHDF IS POISED TO BE THE FASTEST-GROWING SEGMENT DURING 2015-2020
  • FIGURE 16: ASIA-PACIFIC IS POISED TO GROW AT THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD
  • FIGURE 17: BAXTER WILL CONTINUE TO DOMINATE THE GLOBAL CRRT MARKET DURING FORECAST PERIOD
  • FIGURE 18: HIGH POTENTIAL AND APPLICATIONS OF CRRT TO INCREASE ITS SHARE IN THE HIGH-MARGIN AKI MARKET
  • FIGURE 19: MARKET GROWTH WILL BE DRIVEN BY THE RISING PREVALENCE OF AKI
  • FIGURE 20: DIALYSATE & REPLACEMENT FLUIDS PRODUCT SEGMENT AND CVVH MODALITY SEGMENT WILL DOMINATE THE CRRT MARKET
  • FIGURE 21: CVVH DOMINATES THE ASIA-PACIFIC CRRT MARKET IN 2015
  • FIGURE 22: U.S. TO DOMINATE GLOBAL CRRT MARKET IN THE NEXT FIVE YEARS
  • FIGURE 23: CRRT MARKET SEGMENTATION
  • FIGURE 24: CRRT MARKET SEGMENTATION, BY PRODUCT
  • FIGURE 25: CRRT MARKET SEGMENTATION, BY MODALITY
  • FIGURE 26: CRRT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 27: CRRT MARKET IS EXPECTED TO GROW INLINE WITH RISING PREVALENCE OF AKI
  • FIGURE 28: RISE IN GLOBAL ADOPTION OF CRRT FOR THE TREATMENT OF AKI
  • FIGURE 29: KEY FACTORS AFFECTING REIMBURSEMENT RATES FOR CRRT PROCEDURES
  • FIGURE 30: REIMBURSEMENT SCENARIO OF CRRT IN 2015
  • FIGURE 31: REIMBURSEMENT STRUCTURES VARY WIDELY ACROSS EUROPE
  • FIGURE 32: KEY REGULATORY BODIES INVOLVED IN THE APPROVAL OF NEW CRRT PRODUCTS
  • FIGURE 33: PORTER'S FIVE FORCES ANALYSIS - GLOBAL CRRT MARKET
  • FIGURE 34: DESIGN RECOMMENDATIONS FOR CRRT MACHINES
  • FIGURE 35: UTILIZATION OF CRRT AND DIALYSIS FOR THE TREATMENT OF RENAL PATIENTS IN ICU, BY REGION (2014)
  • FIGURE 36: RATE OF SWITCHING FROM CRRT TO IHD, BY REGION, 2014
  • FIGURE 37: NUMBER OF CRRT PATIENTS ACROSS THE GLOBE, 2014
  • FIGURE 38: EUROPE WILL DOMINATE THE OVERALL CRRT MARKET (2015 VS. 2020)
  • FIGURE 39: DISPOSABLES FORM THE FASTEST-GROWING BUSINESS WITHIN THE GLOBAL CRRT INDUSTRY
  • FIGURE 40: HEMOFILTERS TO DOMINATE THE CRRT DISPOSABLES MARKET DURING FORECAST PERIOD
  • FIGURE 41: TYPES OF CRRT MODALITIES
  • FIGURE 42: CVVHDF SEGMENT TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 43: EUROPE TO DOMINATE THE OVERALL CVVH MARKET DURING FORECAST PERIOD
  • FIGURE 44: EUROPE IS ESTIMATED TO ACCOUNT FOR THE MAJOR SHARE OF THE TOTAL CVVHDF MARKET IN 2015
  • FIGURE 45: GROWTH IN AKI CASES WORLDWIDE (2010 -2020)
  • FIGURE 46: EUROPE WILL DOMINATE THE OVERALL CRRT MARKET IN THE FORECAST PERIOD
  • FIGURE 47: THE U.S. WILL BE THE MAJOR CONTRIBUTOR TO THE GLOBAL CRRT MARKET IN THE FORECAST PERIOD
  • FIGURE 48: EUROPEAN CRRT MARKET SNAPSHOT: GERMANY WILL CONTINUE TO DOMINATE THE MARKET IN THE FORECAST PERIOD
  • FIGURE 49: GERMANY TO DRIVE THE GROWTH OF CRRT MARKET IN EUROPE
  • FIGURE 50: CVVH ACCOUNTED FOR THE MAJOR SHARE OF THE EUROPEAN CRRT MARKET IN 2015
  • FIGURE 51: NORTH AMERICAN CRRT MARKET SNAPSHOT: U.S. WILL BE THE MAJOR CONTRIBUTOR TO MARKET GROWTH IN THE FORECAST PERIOD
  • FIGURE 52: ASIA-PACIFIC CRRT MARKET SNAPSHOT: CHINA WILL BE THE FASTEST-GROWING COUNTRY IN THE REGION
  • FIGURE 53: CHINA WILL BE THE FASTEST-GROWING COUNTRY IN THE ASIA-PACIFIC CRRT MARKET IN THE FORECAST PERIOD
  • FIGURE 54: DIALYSATE & REPLACEMENT FLUIDS SEGMENT ACCOUNTS FOR THE MAJOR SHARE OF THE ROW CRRT MARKET, BY PRODUCT, IN 2015
  • FIGURE 55: SCORING METHODOLOGY
  • FIGURE 56: COMPARISON OF COMPETITIVE INTENSITY SCORES: BAXTER, NXSTAGE, B.BRAUN, AND FRESENIUS
  • FIGURE 57: RELATIVE POSITIONING OF COMPANIES BASED ON COMPETITIVE INTENSITY SCORE AND CRRT FOCUS
  • FIGURE 58: GLOBAL CRRT PRODUCTS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014
  • FIGURE 59: GEOGRAPHICAL PRESENCE OF KEY PLAYERS IN CRRT MARKET, 2014
  • FIGURE 60: BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
  • FIGURE 61: FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT
  • FIGURE 62: NIKKISO CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 63: B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • FIGURE 64: NXSTAGE MEDICAL, INC.: COMPANY SNAPSHOT
  • FIGURE 65: ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
  • FIGURE 66: TORAY GROUP: COMPANY SNAPSHOT
Back to Top